Literature DB >> 26309683

The assesment of follicular fluid presepsin levels in poor ovarian responder womenandits relationship with the reproductive outcomes.

Ali Ovayolu1, Özkan Özdamar2, İsmet Gün1, Cansev Y Arslanbuğa3, Tayfun Kutlu1, Gülden Tunalı1, Ramazan Uluhan3.   

Abstract

A considerable proportion of all women undergoing IVFrespond poorly to gonadotropin stimulation. These women are reported to be associated with increased cancellation rates and lower pregnancy rates. It has been hypothesized that poor response to ovarian stimulation is a first sign of ovarian ageing or premature ovarian failure, which might be related to altered inflammatory response in the body. We aimed to compare follicular fluid presepsin levels between poor- and normo-responder patients to ovarian stimulation, to assess its relationship with reproductive outcomes. This study included infertility patients who underwent ovulation induction with either long GnRH agonist or GnRH antagonist protocols and who subsequently underwent IVF/ICSI. Included patients were assigned to two groups according to the Bologna criteria for poor ovarian response. Group 1 and 2 consisted of normo- and poor-responder patients, respectively.The 2 groups were compared in terms of FF presepsin levels. Also, any relationship between the FF presepsin levels and fertility outcomes was assessed within the groups. The groups were compared by using student's t-test, Mann-Whitney U test and X(2) test, where appropriate. Pregnancy rates were not significantly different between the groups (22.6% and 17.6%; P=0.650, respectively). FF presepsin levels were higher in Group 1, however, the difference was not statistically significant (298.0±797.4 and 149.2±422.3; P=0.190, respectively). FF presepsin levels did not significantly differ between pregnancy positive and the pregnancy negative patients in both Group 1 (243.6±531.1 and 314.3±866.5; P=0.055, respectively) and Group 2 (112.2±79.8 and 157.1±464.3; P=0.394, respectively). Consequently, FF presepsin seems not to be a reliable marker in predicting pregnancy in both normo-responder and poor-responder infertility groups.

Entities:  

Keywords:  Presepsin; follicular fluid; infertility; poor responder

Year:  2015        PMID: 26309683      PMCID: PMC4538036     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  35 in total

1.  Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis.

Authors:  Yasunori Yaegashi; Kamon Shirakawa; Nobuhiro Sato; Yasushi Suzuki; Masahiro Kojika; Satoko Imai; Gaku Takahashi; Michiko Miyata; Shoji Furusako; Shigeatsu Endo
Journal:  J Infect Chemother       Date:  2005-10       Impact factor: 2.211

2.  Pathfast presepsin assay for early diagnosis of bacterial infections in surgical patients: preliminary study.

Authors:  G Novelli; V Morabito; G Ferretti; F Pugliese; F Ruberto; F Venuta; L Poli; M Rossi; P B Berloco
Journal:  Transplant Proc       Date:  2013-09       Impact factor: 1.066

3.  Soluble CD14 acts as a negative regulator of human T cell activation and function.

Authors:  J E Rey Nores; A Bensussan; N Vita; F Stelter; M A Arias; M Jones; S Lefort; L K Borysiewicz; P Ferrara; M O Labéta
Journal:  Eur J Immunol       Date:  1999-01       Impact factor: 5.532

4.  Reduced ovarian reserve in patients with Takayasu arteritis.

Authors:  Andrea Rocha S Mont'Alverne; Rosa Maria R Pereira; Lucas Yugo S Yamakami; Vilma Santos T Viana; Edmund Chada Baracat; Eloisa Bonfá; Clovis Artur Silva
Journal:  J Rheumatol       Date:  2014-08-15       Impact factor: 4.666

Review 5.  Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers.

Authors:  Michele Mussap; Antonio Noto; Marco Fravega; Vassilios Fanos
Journal:  J Matern Fetal Neonatal Med       Date:  2011-10

Review 6.  Management of poor responders in IVF.

Authors:  F M Ubaldi; L Rienzi; S Ferrero; E Baroni; F Sapienza; L Cobellis; E Greco
Journal:  Reprod Biomed Online       Date:  2005-02       Impact factor: 3.828

7.  The levels of C-reactive protein in women treated by IVF.

Authors:  Miriam Almagor; Albert Hazav; Haim Yaffe
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

Review 8.  Clinical management of low ovarian response to stimulation for IVF: a systematic review.

Authors:  B C Tarlatzis; L Zepiridis; G Grimbizis; J Bontis
Journal:  Hum Reprod Update       Date:  2003 Jan-Feb       Impact factor: 15.610

9.  Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981.

Authors:  J E Garcia; G S Jones; A A Acosta; G Wright
Journal:  Fertil Steril       Date:  1983-02       Impact factor: 7.329

10.  Ovarian follicular cells have innate immune capabilities that modulate their endocrine function.

Authors:  Shan Herath; Erin J Williams; Sonia T Lilly; Robert O Gilbert; Hilary Dobson; Clare E Bryant; I Martin Sheldon
Journal:  Reproduction       Date:  2007-11       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.